AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

EMVISION MEDICAL DEVICES LTD

1.645

-0.090-5.19%

Volume:7K

Turnover:12.12K

Market Cap:152.88M

PE:-18.02

High:1.670

Open:1.670

Low:1.645

Close:1.735

52wk High:2.210

52wk Low:1.470

Shares:92.94M

Float Shares:56.04M

Volume Ratio:0.37

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.091

EPS(LYR):-0.091

ROE:-66.39%

ROA:-27.75%

PB:9.70

PE(LYR):-18.02

Loading ...

Overview Company News Filings

EMVision Medical Devices Completes First In-Field Feasibility Study of First Responder Brain Scanner

MT Newswires Live

EMVision Says Brain Scanner Clinical Study in South Australia to Show Ability to Provide Timely Stroke Diagnosis

MT Newswires Live

EMVision Medical Devices Says Recruitment for Brain Scanner Validation Trial Surpasses 200 Patients

MT Newswires Live

ASX Penny Stocks Spotlight: Ardea Resources And Two More Picks

Simply Wall St.

ASX Penny Stocks To Watch In July 2026

Simply Wall St.

EMVision Prepares to Add Acute Ischemia Detection Endpoint to Brain Scanner Validation Trial; Shares Up 8%

MT Newswires Live

EMVision Medical Devices Secures AU$1.2 Million IGP Grant After First Responder Milestone

MT Newswires Live

EMvision Medical Devices Ltd-Emvision to Receive $1.17M Igp Grant Instalment

THOMSON REUTERS

EMVision Medical Devices Expands Brain Scanner Pivotal Trial

MT Newswires Live

3 ASX Penny Stocks With Over A$100M Market Cap

Simply Wall St.

EMVision Medical Devices Says Eight Hospitals Recruiting For Validation Trial

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/EMV.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"EMV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EMV.AU\",,,,,undefined,":{"symbol":"EMV.AU","market":"AU","secType":"STK","nameCN":"EMVISION MEDICAL DEVICES LTD","latestPrice":1.645,"timestamp":1789625520000,"preClose":1.735,"halted":0,"volume":7346,"delay":0,"changeRate":-0.05187319884726229,"nameEN":"EMVISION MEDICAL DEVICES LTD","floatShares":56036873,"shares":92938604,"eps":-0.0913,"marketStatus":"Closed","change":-0.09,"latestTime":"09-17 16:12:00 AEST","open":1.67,"high":1.67,"low":1.645,"amount":12120,"amplitude":0.014409,"askPrice":1.74,"askSize":2000,"bidPrice":1.645,"bidSize":553,"shortable":3,"etf":0,"ttmEps":-0.0913,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789689600000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":1.735,"openAndCloseTimeList":[[1789603200000,1789624800000]],"volumeRatio":0.36668,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"EMV.AU","preClose":1.735,"auctionPrice":1.645,"auctionVolume":180,"auctionTime":1789625397600,"referencePrice":1.645,"referenceTime":1789626090714,"auction":3,"marketStatus":"盘后竞价","timestamp":1789625397600}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EMV.AU\",,,,,undefined,":{"symbol":"EMV.AU","floatShares":56036873,"roa":"-27.75%","roe":"-66.39%","lyrEps":-0.0913,"volumeRatio":0.36668,"shares":92938604,"dividePrice":0,"high":1.67,"amplitude":0.014409,"preClose":1.735,"low":1.645,"week52Low":1.47,"pbRate":"9.70","psRate":"18.29","week52High":2.21,"institutionHeld":0,"latestPrice":1.645,"committee":-0.566784,"eps":-0.0913,"divideRate":0,"volume":7346,"delay":0,"ttmEps":-0.0913,"open":1.67,"prevYearClose":1.78,"prevWeekClose":1.745,"prevMonthClose":1.71,"prevQuarterClose":1.515,"fiveDayClose":1.745,"twentyDayClose":1.795,"sixtyDayClose":1.48},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EMV.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EMV.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EMV.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667678908","title":"EMVision Medical Devices Completes First In-Field Feasibility Study of First Responder Brain Scanner","url":"https://stock-news.laohu8.com/highlight/detail?id=2667678908","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667678908?lang=en_us&edition=fundamental","pubTime":"2026-09-16 08:14","pubTimestamp":1789517667,"startTime":"0","endTime":"0","summary":"EMVision Medical Devices  completed the first in-field feasibility study of its First Responder brain scanner, in collaboration with the Melbourne Mobile Stroke Unit, Australia's first mobile stroke unit, operating out of the Royal Melbourne Hospital, according to a Wednesday Australian bourse filing.The company said that primary usability and workflow objectives were achieved during the first deployment of its portable device in a road-vehicle setting.The company added that it has received an Industry Growth Program  progress payment of AU$650,437, while a memorandum of understanding has been signed with the Australian Stroke Alliance to pursue research and translational funding for pre-hospital stroke diagnosis.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","XKO.AU","EMV.AU","BK7007","XJO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664828357","title":"EMVision Says Brain Scanner Clinical Study in South Australia to Show Ability to Provide Timely Stroke Diagnosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2664828357","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664828357?lang=en_us&edition=fundamental","pubTime":"2026-09-03 09:38","pubTimestamp":1788399505,"startTime":"0","endTime":"0","summary":"EMVision Medical Devices  said a clinical study in South Australian regional hospitals will be conducted with its emu bedside brain scanner to demonstrate the ability to provide more timely stroke diagnosis, according to a Thursday Australian bourse filing.The study will be conducted under a project funded by the Australian Government's Cooperative Research Centres Projects . A CRC-P progress payment of AU$337,425 was received in August.The study targets regional and remote hospitals without ready on site-computed tomography access.Site visits were completed, and protocol and ethics preparation are well advanced. Next steps include protocol finalisation, ethics approval, site contracting, and research governance approvals.Its shares were up 1% in recent trading on Thursday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IIGF.AU","DACE.AU","IMLC.AU","BEAR.AU","BBOZ.AU","EMV.AU","XKO.AU","VAP.AU","OZF.AU","QRE.AU","BK7007","IISV.AU","XJO.AU","VAS.AU","ZYAU.AU","XAO.AU","QFN.AU","SLF.AU","IOZ.AU","OZR.AU","E200.AU","STW.AU","EIGA.AU","ABIL","GEAR.AU","GIVE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663402352","title":"EMVision Medical Devices Says Recruitment for Brain Scanner Validation Trial Surpasses 200 Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2663402352","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663402352?lang=en_us&edition=fundamental","pubTime":"2026-08-31 08:46","pubTimestamp":1788137161,"startTime":"0","endTime":"0","summary":"EMVision Medical Devices  said recruitment for its pivotal validation trial for its point-of-care emu brain scanning device surpassed 200 patients across the training and primary analysis groups, according to a Monday Australian bourse filing.The emu device was incorporated into \"code stroke\" workflows at participating hospitals, and no device-related adverse events had been reported to date, the company said. The company is also adding additional US academic medical centers to the trial, expanding recruitment capacity.The primary objective of the trial is to demonstrate hemorrhage detection sensitivity and specificity of greater than 80%.The medical device company's shares added about 2% in recent Monday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EMV.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659619133","title":"ASX Penny Stocks Spotlight: Ardea Resources And Two More Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2659619133","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659619133?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:08","pubTimestamp":1786586920,"startTime":"0","endTime":"0","summary":"The Australian share market is showing signs of a soft opening, with S&P/ASX 200 futures down slightly, reflecting broader global economic trends and cautious investor sentiment. Despite this backdrop, the allure of penny stocks remains strong for investors seeking opportunities in smaller or newer companies. These stocks, though often overlooked due to their lower price points, can offer significant value and growth potential when supported by solid financials. In this article, we explore...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/7113000-choice1-main-header/1585186663023","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7113000-choice1-main-header/1585186663023"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/diversified-financials/asx-obl/omni-bridgeway-shares/news/asx-penny-stocks-spotlight-ardea-resources-and-two-more-pick","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/diversified-financials/asx-obl/omni-bridgeway-shares/news/asx-penny-stocks-spotlight-ardea-resources-and-two-more-pick","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ARL.AU","OBL.AU","BK7095","EMV.AU","BK7091","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651499585","title":"ASX Penny Stocks To Watch In July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651499585","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651499585?lang=en_us&edition=fundamental","pubTime":"2026-07-16 03:02","pubTimestamp":1784142128,"startTime":"0","endTime":"0","summary":"The Australian stock market is showing signs of optimism, with a 50-point advance expected following positive developments in U.S. bank earnings and consumer prices. Amid these broader economic trends, investors may find opportunities in the realm of penny stocks—companies that, despite their modest price tags and somewhat outdated moniker, continue to hold potential for significant returns when backed by strong financials. This article will explore three such penny stocks that combine...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-emv/emvision-medical-devices-shares/news/asx-penny-stocks-to-watch-in-july-2026-6","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-emv/emvision-medical-devices-shares/news/asx-penny-stocks-to-watch-in-july-2026-6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PRN.AU","EMV.AU","BK7015","BK7095","ABB.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651363594","title":"EMVision Prepares to Add Acute Ischemia Detection Endpoint to Brain Scanner Validation Trial; Shares Up 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651363594","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651363594?lang=en_us&edition=fundamental","pubTime":"2026-07-15 11:34","pubTimestamp":1784086464,"startTime":"0","endTime":"0","summary":"EMVision Medical Devices  is advancing preparations to add an acute ischemia detection endpoint to its pivotal validation trial for its point-of-care brain scanning device, with US Food and Drug Administration  meeting and protocol amendment planned, according to a Wednesday Australian bourse filing.The trial is a multi-center, prospective, blinded diagnostic performance study designed to support US FDA De Novo clearance for its emu brain scanner product, per the filing. The primary objective of the trial is to demonstrate hemorrhage detection sensitivity and specificity of greater than 80%.A first responder aeromedical feasibility and usability study for its pre-hospital brain scanning device with Royal Flying Doctor Service was completed during the June quarter, the filing said.The company's shares rose past 8% in recent trading on Wednesday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","EMV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638403583","title":"EMVision Medical Devices Secures AU$1.2 Million IGP Grant After First Responder Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2638403583","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638403583?lang=en_us&edition=fundamental","pubTime":"2026-05-25 07:52","pubTimestamp":1779666776,"startTime":"0","endTime":"0","summary":"EMVision Medical Devices  has confirmed that it has met the required progress under its first responder program, triggering the next grant instalment of AU$1.2 million from the Australian Government's industry growth program , which is expected to be received in May, according to a Monday filing with the Australian bourse.The funding forms part of a AU$5 million non-dilutive grant awarded in June 2025 to support the commercialization of its first responder brain scanner, a portable device intended for pre-hospital use in emergency road and aeromedical settings, per the filing.Payments are disbursed quarterly in advance, subject to eligible spending and milestone delivery, with the company having received AU$1 million so far and AU$2.8 million remaining under the grant facility, the filing added.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","EMV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638588312","title":"EMvision Medical Devices Ltd-Emvision to Receive $1.17M Igp Grant Instalment","url":"https://stock-news.laohu8.com/highlight/detail?id=2638588312","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638588312?lang=en_us&edition=fundamental","pubTime":"2026-05-25 06:20","pubTimestamp":1779661207,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260524:nTUE8PBHTJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","EMV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634475209","title":"EMVision Medical Devices Expands Brain Scanner Pivotal Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2634475209","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634475209?lang=en_us&edition=fundamental","pubTime":"2026-05-11 11:09","pubTimestamp":1778468959,"startTime":"0","endTime":"0","summary":"EMVision Medical Devices  is set to expand its emu brain scanner pivotal validation trial, adding an acute ischemia detection feature to the study following progress in its parallel continuous innovation study, according to a Monday filing with the Australian bourse.Trial recruitment has surpassed 125 total patients, as of early May, across eight active US and Australian hospitals, the filing said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EMV.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629177184","title":"3 ASX Penny Stocks With Over A$100M Market Cap","url":"https://stock-news.laohu8.com/highlight/detail?id=2629177184","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629177184?lang=en_us&edition=fundamental","pubTime":"2026-04-21 03:02","pubTimestamp":1776711742,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the Australian market has remained flat, but it has risen by 14% over the past year, with earnings expected to grow by 12% per annum in the coming years. The term 'penny stocks' might feel like a relic of past market eras, but they continue to offer potential value and growth opportunities when backed by strong financials. In this article, we explore several penny stocks that stand out for their financial strength and potential long-term growth.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-acl/australian-clinical-labs-shares/news/3-asx-penny-stocks-with-over-a100m-market-cap-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-acl/australian-clinical-labs-shares/news/3-asx-penny-stocks-with-over-a100m-market-cap-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7088","BK7058","CLX.AU","BK7012","BK7104","XKO.AU","AEF.AU","BK7124","BK7083","GWA.AU","CGS.AU","BK7132","RPL.AU","EMV.AU","IRI.AU","BK7094","BKY.AU","LBL.AU","PPS.AU","XAO.AU","BK7016","ACL.AU","EDU.AU","OBM.AU","BK7007","BK7062","BK7503","XJO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627482249","title":"EMVision Medical Devices Says Eight Hospitals Recruiting For Validation Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627482249","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627482249?lang=en_us&edition=fundamental","pubTime":"2026-04-13 14:54","pubTimestamp":1776063270,"startTime":"0","endTime":"0","summary":"EMVision Medical Devices  said eight hospitals are actively recruiting and ramping up, expanding trial capacity and supporting increased patient screening activity for its validation trial, according to a Monday Australian bourse filing.The trial is a blinded diagnostic performance study to support the US Food and Drug Administration De Novo clearance for EMVision's emu point-of-care brain scanner product.No device-related adverse events have been reported, it said.It also said the emu Regional Benefits study is advancing through preparations ahead of launch in the second half, with a second grant payment of AU$400,000 received during the quarter.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","EMV.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}]}}